Gefitwel 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Getwell oncology Pvt Ltd
  4. Gefitwel 250 mg Tablet

Gefitwel 250 mg Tablet

Gefitwel 250 mg Tablet contains gefitinib 250 mg and is an oral anticancer medicine used for the treatment of non-small cell lung cancer. It is taken once daily with or without food according to the prescribed treatment plan. Gefitinib works by blocking the epidermal growth factor receptor (EGFR), which can help slow the growth of cancer cells.

BUY NOW

Category

Gefitwel is an EGFR tyrosine kinase inhibitor indicated for selected patients with locally advanced or metastatic non-small cell lung cancer. Its action interferes with EGFR signaling pathways involved in the growth and survival of cancer cells. The recommended dose stated in the manufacturer’s prescribing information is one 250 mg tablet daily, while treatment decisions should be made by the treating oncologist. Common treatment-related effects include diarrhea, skin rash, acne, dry skin, nausea, and vomiting, and new respiratory symptoms require prompt medical evaluation.

Technical Specification

Specification Details
Active Ingredient Gefitinib
Strength 250 mg
Dosage Form Tablet
Recommended Dose 250 mg once daily
Route of Administration Oral
Manufacturer Getwell Oncology Pvt Ltd

Product Also Known As

Gefitwel 250mg Tablet, Gefitwel 250 mg Tablet, Gefitinib 250mg Tablet, Gefitinib 250 mg Tablet, Gefitinib Tablets 250mg, Gefitinib EGFR Inhibitor Tablet